The Pacific Meso Center at the Pacific Heart, Lung, & Blood Institute
Extramural Research Grant Policy
The Pacific Meso Center at the Pacific Heart, Lung, & Blood Institute’s (PMC/PHLBI’s) mission is to serve mesothelioma victims by supporting translational research that improves victims’ lives and longevity, by approaching malignant pleural mesothelioma a chronic, treatable disease. The exploration of innovative ideas forms the foundation of PMC/PHLBI’s unique research program and holds the promise of future treatment breakthroughs. PMC/PHLBI believes that a collaborative research effort can accelerate the acquisition of knowledge more effectively and efficiently than a simple aggregate of independent research projects which have no thematic integration. In this regard, PMC/PHLBI always is soliciting exceptional and innovative research ideas for both collaboration and funding. PMC/PHLBI’s extramural research grant applications encompassing novel ideas that fall into one of PMC/PHLBI’s designated priority areas (see below) may be submitted directly to PMC/PHLBI by investigators who hold a doctoral degree (MD, PhD, DO, DrPH or equivalent) at any academic or not-for-profit institution in the United States or Canada. Such grants periodically will be considered for active funding to the extent allowed by PMC/PHLBI’s budget, which is determined by the generosity of our many donors. Grants submitted to PMC/PHLBI may be related to bench or clinical work but must have a reasonable potential for providing imminent translational impact for mesothelioma patients in terms of diagnosis, treatment, or quality of life. All grants will be reviewed in a two stage manner, first by PMC/PHLBI’s appropriate scientific advisory board and then by PMC/PHLBI’s Board of Directors for ultimate funding decisions.
- Applicants will be judged on:
- Scientific merit
- Suitability based on PMC/PHLBI’s priorities and current projects
- Potential benefits for mesothelioma patients
- Investigator experience
- Research environment
- Collaboration with PMC/PHLBI’s laboratories (if any)
- Mesothelioma investigator career development plan (if any)
- Research priorities include but are not limited to:
- Thermal therapy
- Immunology and immunotherapy
- Tumor microenvironment and its modification
- Stem cell and gene therapies
- Intra-operative therapies
- Due to limited resources, PMC/PHLBI’s policy allows only 2-5% indirect institutional costs for non-salary research costs depending on the projects specific needs
- Grants should be submitted using PHS 398 forms which are available at the NIH website at http://grants.nih.gov/grants/funding/phs398/phs398.html and limited to no more than 12 pages in length excluding supporting documentation such as references, appendices, budgets, biosketches, and letters of support.
If you would like a free copy, "Mesothelioma: A Patient's Road Map", please click on image cover below:
If you like to receive a hard-copy by mail, please contact us at (310) 478-4678 or firstname.lastname@example.org.